Hee Kap Kang, Ph.D.

Hee Kap Kang, Ph.D.

2006-2007

A Lupus Therapy without Toxicity
Image
Hee Kap Kang, Ph.D.

Northwestern University

Chicago, IL
Mechanism of Low-dose Tolerance with Nucleosomal Peptides in Lupus

Dr. Kang has developed a therapy to repair a cell defect which may cause lupus. To test this therapy, Dr. Kang’s lab is studying the effects of the injection of a peptide into a lupus-prone mouse.

Healthy subjects and family members of lupus patients, who might be at risk of developing lupus (as predicted by genetic and biomarkers), might benefit from the peptide therapy because it repairs a defect in regulatory T cell deficiency in lupus.

To recognize his exemplary work, Dr. Kang has been awarded the honor being named the Eng Tan Scholar. Eng Tan, M.D., retired in 2005 from The Scripps Research Institute in La Jolla, CA, was a founding member of the ANRF Scientific Advisory Board and is a world-renowned researcher and clinician in rheumatic diseases and immunology.

ANRF
Article Author
Arthritis National Research Foundation
arthritisresearch@curearthritis.org

The Arthritis National Research Foundation's mission is to provide initial research funding to brilliant, investigative scientists with new ideas to cure arthritis and related autoimmune diseases. Writing articles about the patients affected and the science being done to find a cure shows why we need to come together to #CureArthritis!

No Comments

Sorry, the comment form is closed at this time.